Biochemical separation of a human B cell mitogenic factor.

PubWeight™: 1.68‹?› | Rank: Top 3%

🔗 View Article (PMC 347039)

Published in Proc Natl Acad Sci U S A on October 01, 1982

Authors

A Maizel, C Sahasrabuddhe, S Mehta, J Morgan, L Lachman, R Ford

Articles citing this

Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. J Exp Med (1984) 2.74

Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays. J Exp Med (1983) 2.56

Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function. J Exp Med (1985) 2.14

B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation. J Exp Med (1983) 1.73

Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia. Proc Natl Acad Sci U S A (1984) 1.47

Defective DNA synthesis by T cells in acquired 'common-variable' hypogammaglobulinaemia on stimulation with mitogens. Clin Exp Immunol (1989) 1.32

Long-term growth of human B cells and their use in a microassay for B-cell growth factor. Proc Natl Acad Sci U S A (1983) 1.20

Increasing the intracellular Na+ concentration induces differentiation in a pre-B lymphocyte cell line. Proc Natl Acad Sci U S A (1983) 1.08

Selective inhibition of growth factor-dependent human B cell proliferation by monoclonal antibody AB1 to an antigen expressed by activated B cells. J Exp Med (1984) 1.00

Development of a human T-cell hybridoma secreting separate B-cell growth and differentiation factors. Proc Natl Acad Sci U S A (1984) 0.97

Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity. Proc Natl Acad Sci U S A (1986) 0.90

Phorbol ester and calcium ionophore are sufficient to promote cell replication in cultures of quiescent human B lymphocytes. Immunology (1989) 0.87

Immortalization of human lymphocytes by fusion with cytoplasts of transformed mouse L cells. J Cell Biol (1986) 0.83

Growth factor-mediated tumor cell proliferation in hairy cell leukemia. J Exp Med (1985) 0.83

Differential responsiveness of human B lymphocytes to phorbol ester and calcium ionophore based on their state of activation. Immunology (1989) 0.81

Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors. Clin Exp Immunol (1989) 0.80

Stimulation of lymphoid cell proliferation by Mycoplasma orale, a common cell culture contaminant. Infect Immun (1985) 0.79

Leukaemia x fibroblast hybrid cells augment the antibody response to sheep red blood cells in inbred mice. Immunology (1985) 0.75

Negative modulation of Epstein-Barr virus episomes by a human B-cell growth factor. J Virol (1989) 0.75

Evidence for an intracellular precursor for human B-cell growth factor. Proc Natl Acad Sci U S A (1984) 0.75

Response of neoplasms of B cell lineage to the proliferative effects of B cell growth factor and the phorbol ester TPA. Am J Pathol (1989) 0.75

IgA specific helper factor (alpha HF) in human colostrum. Clin Exp Immunol (1986) 0.75

Articles cited by this

High resolution two-dimensional electrophoresis of proteins. J Biol Chem (1975) 133.45

A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22

Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol (1972) 40.51

Identification of a T cell-derived b cell growth factor distinct from interleukin 2. J Exp Med (1982) 9.49

Specific purification of lymphocyte populations on a digestible immunoabsorbent. J Immunol (1973) 6.64

The functional relationship of the interleukins. J Exp Med (1980) 5.62

Labeling of proteins by reductive methylation using sodium cyanoborohydride. J Biol Chem (1979) 5.42

Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. Proc Natl Acad Sci U S A (1980) 4.91

The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses. Immunol Rev (1982) 4.43

Two distinct factors are required for induction of T-cell growth. Nature (1980) 4.13

Growth factors in mammalian cell culture. Annu Rev Biochem (1976) 2.83

T cell-dependent activation of resting B cells: requirement for both nonspecific unrestricted and antigen-specific Ia-restricted soluble factors. Proc Natl Acad Sci U S A (1981) 2.74

Long-term culture of normal mouse B lymphocytes. Proc Natl Acad Sci U S A (1981) 1.94

Human T lymphocyte/monocyte interaction in response to lectin: kinetics of entry into the S-phase. J Immunol (1981) 1.62

Effect of interleukin 1 on human thymocytes and purified human T cells. J Exp Med (1981) 1.50

Long-term culture and cloning of nontransformed human B lymphocytes. J Exp Med (1981) 1.39

Soluble factor activation of human B lymphocytes. Nature (1981) 1.22

Articles by these authors

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer (2009) 77.71

The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell (1992) 5.05

Assessment of the severity of primary depressive illness. Wakefield self-assessment depression inventory. Psychol Med (1971) 3.75

A critical period for macromolecular synthesis in long-term heterosynaptic facilitation in Aplysia. Science (1986) 3.30

A pathological and mineralogical study of asbestos-related deaths in the United Kingdom in 1977. Ann Occup Hyg (1982) 3.00

Indications for cholesterol-lowering medication: comparison of risk-assessment methods. Lancet (1999) 2.75

Who is speaking for children and adolescents and for their health at the policy level? BMJ (2000) 2.75

Molecular cloning and expression of a human B-cell growth factor gene in Escherichia coli. Science (1987) 2.65

Dependence of the putrescine content of Escherichia coli on the osmotic strength of the medium. J Biol Chem (1972) 2.64

Potential factors affecting adherence with HIV therapy. AIDS (1997) 2.44

The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.26

A systematic review of the therapeutic interventions for heterotopic ossification after spinal cord injury. Spinal Cord (2010) 2.18

The role of fiberoptic endoscopy in the management of corrosive ingestion and modified endoscopic classification of burns. Gastrointest Endosc (1991) 2.11

Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: data for genetic counselling. Am J Med Genet (1984) 2.10

Sclerosing Hemangiomas of the Central Nervous System: Progressive Tissue Changes in Hemangioblastomas of the Brain and in SoCalled Angioblastic Menningiomas. Am J Pathol (1942) 2.08

Evaluation of lymph nodes with RECIST 1.1. Eur J Cancer (2008) 2.03

Progeria. Indian Pediatr (1990) 2.03

Facial nuclear degeneration on MRI in bulbar onset amyotrophic lateral sclerosis. QJM (2013) 2.01

Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice. Neuromuscul Disord (2001) 1.97

Painless left hemorrhagic pleural effusion: An unusual presentation of dissecting ascending aortic aneurysm. Chest (1999) 1.94

Direct measurement of the 7Be solar neutrino flux with 192 days of borexino data. Phys Rev Lett (2008) 1.93

Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med (1999) 1.88

Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia. BMJ (2000) 1.80

Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol (2008) 1.77

A randomised controlled study of close monitoring of vulnerable psychiatric patients. Lancet (1995) 1.76

Tendon ruptures in patients with systemic lupus erythematosus treated with corticosteroids. Arthritis Rheum (1975) 1.72

Characterization of two evolutionarily conserved, alternatively spliced nuclear phosphoproteins, NFAR-1 and -2, that function in mRNA processing and interact with the double-stranded RNA-dependent protein kinase, PKR. J Biol Chem (2001) 1.71

Role of interleukin 1 in anti-immunoglobulin-induced B cell proliferation. J Exp Med (1983) 1.69

Esterase activities of human carbonic anhydrases B and C. J Biol Chem (1967) 1.69

Presence of a highly repetitive and widely dispersed DNA sequence in the human genome. Proc Natl Acad Sci U S A (1981) 1.67

SAP90 binds and clusters kainate receptors causing incomplete desensitization. Neuron (1998) 1.63

Purification of human B cell growth factor. J Immunol (1985) 1.61

Branch breakage under snow and ice loads. Tree Physiol (1989) 1.61

Acetylcholine, outer hair cell electromotility, and the cochlear amplifier. J Neurosci (1997) 1.61

Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology (2003) 1.61

Recommendations for the assessment of progression in randomised cancer treatment trials. Eur J Cancer (2009) 1.60

A patient survey of sleep quality in the Intensive Care Unit. Minerva Anestesiol (2012) 1.58

Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development. Cell Growth Differ (1997) 1.57

Systematic review concerning the age of introduction of complementary foods to the healthy full-term infant. Eur J Clin Nutr (2001) 1.57

Reciprocal regulation of anaerobic and aerobic cell wall mannoprotein gene expression in Saccharomyces cerevisiae. J Bacteriol (2001) 1.57

Thymosin beta 4: a ubiquitous peptide in rat and mouse tissues. Proc Natl Acad Sci U S A (1982) 1.56

Urinary tract obstruction and nephrostomy drainage in pelvic malignant disease. Br J Urol (1995) 1.54

Slowly fading super-luminous supernovae that are not pair-instability explosions. Nature (2013) 1.52

The clinical consequences of a stiff left atrium. Am Heart J (1991) 1.52

A series of specific ribonucleoprotein fragments from the 30-S subparticle of Escherichia coli ribosomes. Eur J Biochem (1972) 1.50

Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues. J Pediatr (1997) 1.49

Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int (2000) 1.48

MR imaging before arthroscopy in knee joint disorders? Acta Radiol (1996) 1.47

The risk of aspiration in presence of cuffed endotracheal tubes. Br J Anaesth (1972) 1.47

Relative oral efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice. Blood (1990) 1.47

Ingestion of strong corrosive alkalis: spectrum of injury to upper gastrointestinal tract and natural history. Am J Gastroenterol (1992) 1.47

Morphogenesis and ultrastructure of Geotrichum candidum septa. J Bacteriol (1973) 1.46

Ingestion of corrosive acids. Spectrum of injury to upper gastrointestinal tract and natural history. Gastroenterology (1989) 1.46

Normal colonic epithelium adheres to carcinoembryonic antigen and type IV collagen. Gastroenterology (1994) 1.45

Fungal diarrhoea: association of different fungi and seasonal variation in their incidence. Mycopathologia (1990) 1.44

Giardia lamblia infection in immunosuppressed animals causes severe alterations to brush border membrane enzymes. Dig Dis Sci (1988) 1.44

Cervical screening uptake in immunocompromised women in Waikato, New Zealand. Int J STD AIDS (2010) 1.43

Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42

Does the activation of poly (ADP-ribose) synthetase mediate tissue injury in the sepsis induced by cecal ligation and puncture? Shock (2001) 1.41

End of life care: issues and challenges. J Postgrad Med (2008) 1.40

Dihydroergotamine nasal spray for the acute treatment of migraine. Neurology (1994) 1.40

Effects of althesin anaesthesia and surgery on carbohydrate and fat metabolism in man. Br J Anaesth (1975) 1.40

Preformulation studies. I. Molindone hydrochloride. J Pharm Sci (1973) 1.40

Long-term facilitation in obstructive sleep apnea patients during NREM sleep. J Appl Physiol (1985) (2001) 1.40

Congenital afibrinogenaemia. J Assoc Physicians India (1989) 1.39

Luminous reservoir bag. Br J Anaesth (1969) 1.39

A comparative evaluation of sclerosants for esophageal varices: a prospective randomized controlled study. Gastrointest Endosc (1990) 1.39

Cerebral oxygenation at high altitude and the response to carbon dioxide, hyperventilation and oxygen. The Birmingham Medical Research Expeditionary Society. Clin Sci (Lond) (2000) 1.39

Letter: Death during dental anaesthesia. Br Med J (1974) 1.39

Skeletal manifestations in beta-thalassaemia intermedia. J Assoc Physicians India (1991) 1.39

A passive method of disposal of expired anaesthetic gases. Br J Anaesth (1977) 1.39

Isolation of microfilaments from Amoeba proteus. Exp Cell Res (1967) 1.38

Calculus biliary tract disease in beta-thalassemia trait. Indian Pediatr (1989) 1.38

Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med (1999) 1.38

Autoimmune sclerosing cholangitis: an overlap syndrome in a child. Indian J Gastroenterol (1999) 1.38

The making of a pediatrician. Indian Pediatr (1997) 1.38

A supraglottic oropharyngeal airway. Anaesthesia (1990) 1.37

Event excess in the MiniBooNE search for ¯νμ→¯νe oscillations. Phys Rev Lett (2010) 1.37

Split-hand and split-foot deformity inherited as an autosomal recessive trait. Clin Genet (1976) 1.36

Leg symptoms, the ankle-brachial index, and walking ability in patients with peripheral arterial disease. J Gen Intern Med (1999) 1.35

Generation and characterization of a defined mutant of Streptococcus suis lacking suilysin. Infect Immun (2001) 1.34

Safety and efficacy of a sustained inflation for alveolar recruitment in adults with respiratory failure. Intensive Care Med (1999) 1.34

A prospective study of seroprevalence of Toxoplasmosis in general population, and in HIV/AIDS patients in Bombay, India. J Postgrad Med (2000) 1.33

Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int (1984) 1.33

Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease. Arch Intern Med (1999) 1.31

Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med (1997) 1.30

Pharmacokinetics of FK 506 in transplant patients. Transplant Proc (1991) 1.30

Surveillance of insecticide resistance in head lice using biochemical and molecular methods. Arch Dis Child (2006) 1.29

Study of oxidative-stress in isoniazid-rifampicin induced hepatic injury in young rats. Drug Chem Toxicol (1997) 1.28

CD55 is over-expressed in the tumour environment. Br J Cancer (2001) 1.27

Regional localization of the autosomal dominant polycystic kidney disease locus. Genomics (1988) 1.26

Differential requirement for classic and novel PKC isoforms in respiratory burst and phagocytosis in RAW 264.7 cells. J Immunol (2000) 1.26

Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am J Physiol Lung Cell Mol Physiol (2006) 1.26

Handheld computers in critical care. Crit Care (2001) 1.25

Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J Pediatr (1999) 1.25

Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int (2000) 1.24

Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review. Eur Respir J (2006) 1.23

Fifty years of Journal of Postgraduate Medicine: a journey in time. J Postgrad Med (2004) 1.23